Penumbra, Inc.
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thromb…
Medical - Devices
US, Alameda [HQ]
PEN/Financial Reporting
Income Statements
12 Sheets · Starting from 2023In Million USD. Margins, Growth Rates In %
| Metric | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 73.00 | 88.00 | 125.00 | 186.00 | 263.00 | 333.00 | 444.00 | 547.00 | 560.00 | 747.00 | 847.00 | 1,058.00 | |
|
EPS
|
0.08 | 0.04 | -0.03 | 0.09 | 0.49 | 0.14 | 0.18 | 1.39 | -0.54 | 0.07 | -0.05 | 2.37 | |
| Diluted in mil. | 0.08 | 0.04 | -0.03 | 0.08 | 0.44 | 0.13 | 0.18 | 1.34 | -0.54 | 0.07 | -0.05 | 2.32 | |
|
Profit
|
48.00 | 57.00 | 82.00 | 124.00 | 170.00 | 217.00 | 292.00 | 371.00 | 338.00 | 475.00 | 535.00 | 682.00 | |
| Gross Margin | 66.94 | 65.14 | 66.00 | 66.66 | 64.88 | 65.06 | 65.75 | 67.95 | 60.34 | 63.59 | 63.18 | 64.49 | |
| Pre Tax | 3.00 | -1.00 | 3.00 | 4.00 | - - | 2.00 | 1.00 | 50.00 | -38.00 | -10.00 | 3.00 | 79.00 | |
| Profit Margin | 5.32 | -1.41 | 2.50 | 2.16 | -0.33 | 0.74 | 0.36 | 9.16 | -6.78 | -1.40 | 0.46 | 7.52 | |
| ETR | 49.69 | 426.61 | 28.48 | 41.23 | 1,804.72 | -145.84 | -273.82 | 6.25 | 49.35 | 124.98 | 151.44 | -14.19 | |
| Net | 1.00 | 4.00 | 2.00 | 2.00 | 14.00 | 4.00 | 6.00 | 48.00 | -19.00 | 2.00 | -2.00 | 90.00 | |
| Profit Margin | 2.68 | 4.61 | 1.79 | 1.27 | 5.63 | 1.40 | 1.48 | 8.85 | -3.44 | 0.35 | -0.24 | 8.59 | |
| EBITDA | 3.00 | - - | 3.00 | 4.00 | -1.00 | 1.00 | 60.00 | 47.00 | -38.00 | -7.00 | 6.00 | 126.00 | |
| EBITDA Margin | 4.69 | -0.51 | 3.00 | 2.25 | -0.51 | 0.35 | 13.67 | 8.68 | -6.95 | -1.00 | 0.72 | 11.98 | |
| Operating Income | 3.00 | -1.00 | 3.00 | 4.00 | -1.00 | 1.00 | - - | 47.00 | -38.00 | -7.00 | -18.00 | 73.00 | |
| Operating Margin | 4.69 | -1.27 | 2.40 | 2.25 | -0.51 | 0.35 | -0.19 | 8.68 | -6.95 | -1.00 | -2.15 | 6.95 | |
| Interest Income | - - | - - | - - | - - | - - | - - | - - | 2.00 | 1.00 | - - | - - | 6.00 | |
| Loss | -69.00 | -89.00 | -122.00 | -181.00 | -264.00 | -332.00 | -414.00 | -499.00 | -599.00 | -755.00 | -841.00 | -966.00 | |
| Cost of Revenue | -24.00 | -30.00 | -42.00 | -62.00 | -92.00 | -116.00 | -152.00 | -175.00 | -222.00 | -272.00 | -311.00 | -375.00 | |
|
Operating Expenses
|
-45.00 | -59.00 | -79.00 | -119.00 | -172.00 | -215.00 | -262.00 | -324.00 | -377.00 | -482.00 | -529.00 | -590.00 | |
| R&D | -12.00 | -14.00 | -15.00 | -18.00 | -23.00 | -31.00 | -36.00 | -51.00 | -90.00 | -104.00 | -79.00 | -84.00 | |
| G&A | - - | - - | - - | -101.00 | -148.00 | -184.00 | -226.00 | -272.00 | -286.00 | -377.00 | -448.00 | -505.00 | |
| SG&A | -32.00 | -44.00 | -64.00 | -101.00 | -148.00 | -184.00 | -226.00 | -272.00 | -287.00 | -378.00 | -449.00 | -506.00 | |
| S&M | - - | - - | - - | - - | - - | - - | - - | - - | - - | -1.00 | -1.00 | -1.00 | |
| Depreciation and Amortization | - - | - - | - - | -1.00 | -2.00 | -3.00 | -6.00 | -8.00 | -12.00 | -16.00 | -24.00 | -27.00 | |
| Interest Expenses | - - | - - | - - | - - | - - | - - | - - | - - | - - | -1.00 | - - | -1.00 | |
| Other Expenses | - - | - - | - - | - - | -1.00 | -1.00 | -31.00 | -2.00 | - - | -3.00 | -22.00 | -17.00 | |
|
WA Shares Outstanding
|
24.00 | 24.00 | 24.00 | 11.00 | 30.00 | 32.00 | 36.00 | 34.00 | 35.00 | 36.00 | 37.00 | 38.00 | |
| Diluted | 24.00 | 24.00 | 24.00 | 14.00 | 33.00 | 35.00 | 36.00 | 36.00 | 35.00 | 37.00 | 37.00 | 39.00 |